The Lung Bacteria Laboratory studies the bacterial pathogens common in cystic fibrosis and related suppurative lung diseases.
Its research focuses on:
- mechanisms of cross-infection;
- mechanisms of infection acquisition from the environment and other clinical sources;
- determinants of bacterial virulence;
- persistence and antimicrobial resistance linking genomics with the phenotype;
- clinical outcomes.
The laboratory also aims to improve patient outcomes by understanding optimal treatment for chronic infection, and to provide improved diagnostics that result in earlier and more accurate infection-detection.
Further research is focused on investigating acquisition and transmission pathways for common CF pathogens and with a particular focus on non-tuberculous mycobacteria (an infection increasingly common in patients with CF and other lung diseases).
Honorary Group Leader: Professor Scott Bell
- Dr Laura Sherrard, Visiting Scientist
- Rebecca Stockwell, Research Assistant
- Michelle Wood, MPhil Student
- Christine Duplancic, Research Officer
- Kay Ramsay, PhD Student (Non-review)
- Thuy-Khanh Nguyen, Research Officer
- Erin Price, Visiting Scientist
- Derek Sarovich, Visiting Scientist
- Elucidating antibiotic resistance mechanisms in chronic Pseudomonas aeruginosa infection
- The emerging problem of non-tuberculous mycobacteria infection: understanding aetiology, geospatial epidemiology and developing interventions
If you wish to apply for QIMR Berghofer's student program,
click here for more information.